The Lancet Public Health in conversation with

Valery Feigin on the global burden of epilepsy


Listen Later

Valery Feigin speaks to Pierre Nauleau about the Global Burden of Disease study on epilepsy.

Read the full article, Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021, at https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(24)00302-5/fulltext?dgcid=buzzsprout_icw_podcast_lanpub

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

...more
View all episodesView all episodes
Download on the App Store

The Lancet Public Health in conversation withBy The Lancet Group

  • 1
  • 1
  • 1
  • 1
  • 1

1

1 ratings


More shows like The Lancet Public Health in conversation with

View all
This American Life by This American Life

This American Life

91,111 Listeners

Fresh Air by NPR

Fresh Air

38,441 Listeners

Health Check by BBC World Service

Health Check

89 Listeners

6 Minute English by BBC Radio

6 Minute English

1,809 Listeners

Medicine and Science from The BMJ by The BMJ

Medicine and Science from The BMJ

37 Listeners

NEJM This Week by NEJM Group

NEJM This Week

323 Listeners

The Food Chain by BBC World Service

The Food Chain

345 Listeners

Modern Love by The New York Times

Modern Love

8,862 Listeners

Today in Focus by The Guardian

Today in Focus

994 Listeners

On Purpose with Jay Shetty by iHeartPodcasts

On Purpose with Jay Shetty

27,776 Listeners

anything goes with emma chamberlain by emma chamberlain

anything goes with emma chamberlain

62,562 Listeners

The Lancet Voice by The Lancet Group

The Lancet Voice

22 Listeners

The Lancet Child & Adolescent Health in conversation with by The Lancet Group

The Lancet Child & Adolescent Health in conversation with

0 Listeners

The Lancet Digital Health in conversation with by The Lancet Group

The Lancet Digital Health in conversation with

0 Listeners

The Lancet Global Health in conversation with by The Lancet Group

The Lancet Global Health in conversation with

2 Listeners

The Lancet Oncology in conversation with by The Lancet Group

The Lancet Oncology in conversation with

2 Listeners

The Lancet Psychiatry in conversation with by The Lancet Group

The Lancet Psychiatry in conversation with

0 Listeners

The Rest Is History by Goalhanger

The Rest Is History

14,026 Listeners

The Lancet Respiratory Medicine in conversation with by The Lancet Group

The Lancet Respiratory Medicine in conversation with

1 Listeners

The Lancet in conversation with by The Lancet Group

The Lancet in conversation with

0 Listeners

The Lancet Haematology in conversation with by The Lancet Group

The Lancet Haematology in conversation with

0 Listeners

The Lancet Gastroenterology & Hepatology in conversation with by The Lancet Group

The Lancet Gastroenterology & Hepatology in conversation with

0 Listeners

The Lancet Diabetes & Endocrinology in conversation with by The Lancet Group

The Lancet Diabetes & Endocrinology in conversation with

1 Listeners

The Lancet Infectious Diseases in conversation with by The Lancet Group

The Lancet Infectious Diseases in conversation with

0 Listeners

The Lancet Microbe in conversation with by The Lancet Group

The Lancet Microbe in conversation with

0 Listeners

In conversation with... by The Lancet Neurology

In conversation with...

0 Listeners

eBioMedicine in conversation with by The Lancet Group

eBioMedicine in conversation with

0 Listeners

eClinicalMedicine in conversation with by The Lancet Group

eClinicalMedicine in conversation with

0 Listeners

The Lancet Rheumatology in conversation with by The Lancet Group

The Lancet Rheumatology in conversation with

0 Listeners

The Rest Is Politics by Goalhanger

The Rest Is Politics

3,309 Listeners

The Retrievals by Serial Productions & The New York Times

The Retrievals

10,287 Listeners

The Lancet Regional Health in conversation with by The Lancet Group

The Lancet Regional Health in conversation with

0 Listeners

The Lancet Regional Health Americas in conversation with by The Lancet Group

The Lancet Regional Health Americas in conversation with

0 Listeners